Compounds > catechol

catechol and bortezomib

catechol has been researched along with bortezomib in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, F; Cryns, VL; Messersmith, PB; Su, J1
Hong, SY; Kang, S; Min, J; Moon, H; Shin, HH; Yang, HJ1
Cheng, Y; Hu, K; Shao, N; Wang, M; Wang, Y1
Huo, Q; Li, Y; Liu, Y; Niu, Y; Shi, H; Xu, M; Yang, F; Zhu, J1
Kuckling, D; Müller, M; Reis, B; Rust, T; Vehlow, D1

Other Studies

5 other study(ies) available for catechol and bortezomib

ArticleYear
Catechol polymers for pH-responsive, targeted drug delivery to cancer cells.
    Journal of the American Chemical Society, 2011, Aug-10, Volume: 133, Issue:31

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Catechols; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Hydrogen-Ion Concentration; Molecular Structure; Polymers; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Structure-Activity Relationship

2011
Development of P22 viral capsid nanocomposites as anti-cancer drug, bortezomib (BTZ), delivery nanoplatforms.
    Macromolecular bioscience, 2014, Volume: 14, Issue:4

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Capsid Proteins; Carcinoma, Hepatocellular; Catechols; Drug Delivery Systems; Humans; Liver Neoplasms; Nanocomposites; Pyrazines

2014
Tumor extracellular acidity activated "off-on" release of bortezomib from a biocompatible dendrimer.
    Biomaterials science, 2015, Volume: 3, Issue:3

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Catechols; Dendrimers; Drug Carriers; Drug Delivery Systems; HeLa Cells; Humans; Hydrogen-Ion Concentration; Nanoparticles; Neoplasms; Polymers

2015
Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy.
    Nanoscale, 2018, Oct-04, Volume: 10, Issue:38

    Topics: Alendronate; Animals; Antineoplastic Agents; Bone Neoplasms; Bortezomib; Breast Neoplasms; Catechols; Cell Line; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Female; Hemolysis; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Prodrugs; Proteasome Inhibitors; RAW 264.7 Cells

2018
Thermoresponsive Catechol Based-Polyelectrolyte Complex Coatings for Controlled Release of Bortezomib.
    International journal of molecular sciences, 2019, Dec-02, Volume: 20, Issue:23

    Topics: Bortezomib; Caffeic Acids; Catechols; Coated Materials, Biocompatible; Delayed-Action Preparations; Drug Delivery Systems; Humans; Methacrylates; Multiple Myeloma; Polyelectrolytes; Polymers

2019